FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
FutureFemHealth Pro
Partners and contributors
Archive
About
What actually counts as continuous hormone monitoring? Why the industry can’t agree
As startups race to build the future of hormone intelligence, three distinct approaches are emerging
12 hrs ago • Anna O'Sullivan
💌 Issue 151: Two acquisitions | Natural Cycles launches sleep insights | Spanish Government invests in women's health
The global weekly briefing on women's health innovation and Femtech
Jun 17 • Anna O'Sullivan
Natural Cycles launches sleep insights designed around the menstrual cycle
New Sleep Insights feature helps women understand how hormonal changes may affect sleep
Jun 16 • Anna O'Sullivan
How Qatar is introducing global women's health startups to the Middle East region
When Qatar Science & Technology Park (QSTP) launched a new FemTech accelerator earlier this year, applications arrived from 47 countries.
Jun 16 • Anna O'Sullivan
The90 launches UV-tracking wearable aimed at personalised sun exposure monitoring
The California-based company says its jewellery-style device measures real-time UVA and UVB exposure, with backing from beauty entrepreneur and investor…
Jun 15 • Anna O'Sullivan
What it takes to get reimbursed in women’s health - the Hello Inside story
The 18-month company rebuild behind Hello Inside’s deal with Germany's statutory insurer BARMER
Jun 12 • Anna O'Sullivan
💌 Issue 150: $215m for women's health | Apple adds menopause | Impli secures £1.4m NIHR grant | Ida Tin on continuous hormone monitoring
Welcome to issue #150 of FutureFemHealth, (w/c June 9 2026) — the global weekly briefing on women’s health innovation.
Jun 10 • Anna O'Sullivan
Why Ida Tin and SPRIND are building the future of continuous hormone monitoring
The founder of Clue discusses the vision behind SPRIND's €40 million Hormone Challenge and why no single startup can solve the problem alone.
Jun 9 • Anna O'Sullivan
Impli secures £1.4M NIHR grant to advance continuous hormone monitoring for IVF
"Continuous hormone monitoring has the potential to change the landscape of fertility treatment"
Jun 8 • Anna O'Sullivan
Irish fertility intelligence startup Fertally secures €100,000 Enterprise Ireland backing
Founded after CEO Aisling Mooney's 15-year infertility journey, Fertally is building a platform designed to connect fertility care with the latest…
Jun 8 • Anna O'Sullivan
Collaborate upstream, compete downstream: What salmon farming, airline safety and biopharma can teach FemTech
A case for precompetitive collaboration clusters to advance women’s health innovation.
Jun 8 • Anna O'Sullivan
💌 Issue 149: Flo Health on privacy | Contraline raises $92.5m | Clue makes reimbursement history | UK Government responds on censorship
The global weekly briefing on women's health innovation and Femtech
Jun 3 • Anna O'Sullivan
© 2026 FutureFemHealth Ltd · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture